July 2024 | AIChE

You are here

July 2024

Martín Fernández

Martín Fernández is President of Whycomm, Safety Culture Strategies, a consulting firm focused on the implementation of process safety culture and operational discipline programs.Read more

Saulius Klimašauskas



Saulius Klimašauskas graduated Organic Chemistry at Vilnius University, and then worked on characterization of bacterial DNA methyltransferases with Prof. Arvydas Janulaitis at the Institute of Applied Enzymology Fermentas in Vilnius Lithuania to receive his Ph.D. in Bioorganic Chemistry in 1987. He was a postdoctoral scientist in structural and molecular biology of DNA methyltransferases with Dr. Sir Richard J. Roberts (NL) at Cold Spring Harbor Laboratory in Cold Spring Harbor, New York. After starting his own group in 1995 at the Institute of Biotechnology in Vilnius,...Read more

Kim Kira Witetzek



Kim Kira Witetzek is a Ph.D. student at the Institute of Biomedical Sciences, Academia Sinica in Taiwan. She acquired her Bachelor of Science in Molecular Bio-Medicine at the University of Bonn, Germany and her Master of Science in Molecular Medicine at the University of Freiburg, Germany. For her doctoral studies she joined the group of Prof. Chen Shih-Yu which is specialised on single cell analysis and multi-omics approaches. Her research focuses on integrating chromatin accessibility analysis with multiple omics platforms for a holistic understanding of the epigenome and to...Read more

Petr Sulc



Petr Sulc is an Associate Professor at Arizona State University. He received his master's degree in quantum physics at Ecole Polytechnique, Paris, in 2009, and his D.Phil. degree in theoretical physics at University of Oxford in 2014. He worked as a graduate research assistant at Center for Nonlinear Studies in Los Alamos National lab and was a fellow in physics and biology at the Rockefeller University. In 2018, he established his research group at the Biodesign Institute at Arizona State University. His research broadly encompasses applications of statistical physics and...Read more

Kevin Zhao

Kevin Zhao is a co-founder and Chief Technology Officer of Qi Biodesign, a company dedicated to the advancement of precision genome editing in new crop breeding. He graduated with his PhD from Harvard University in the lab of David Liu where he developed a rapid and continuous protein directed evolution system and used this method to develop new and efficient base editors. Since starting Qi Biodesign with Caixia Gao in 2021, he has published studies in Cell and Nature Biotechnology as a co-corresponding author. Kevin was selected to be on Forbes 30 Under 30...Read more

Pages